KCM
MLAB icon

Kennedy Capital Management’s Mesa Laboratories MLAB Stock Holding History

Kennedy Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.6M Sell
142,343
-2,263
-2% -$195K 0.27% 137
2025
Q4 		$11.4M Buy
144,606
+23,060
+19% +$1.75M 0.24% 155
2025
Q3 		$8.14M Buy
121,546
+31,067
+34% +$2.24M 0.18% 205
2025
Q2 		$8.52M Sell
90,479
-22,792
-20% -$2.5M 0.2% 174
2025
Q1 		$13.4M Buy
113,271
+38,665
+52% +$5.27M 0.32% 89
2024
Q4 		$9.84M Buy
74,606
+8,700
+13% +$1.07M 0.22% 140
2024
Q3 		$8.56M Sell
65,906
-4,473
-6% -$526K 0.19% 177
2024
Q2 		$6.11M Buy
70,379
+10,675
+18% +$1.12M 0.13% 261
2024
Q1 		$6.55M Sell
59,704
-47,363
-44% -$4.77M 0.13% 257
2023
Q4 		$11.2M Sell
107,067
-2,429
-2% -$237K 0.25% 134
2023
Q3 		$11.5M Buy
109,496
+32,412
+42% +$4.15M 0.28% 102
2023
Q2 		$9.91M Buy
77,084
+27,785
+56% +$4.23M 0.23% 144
2023
Q1 		$8.61M Buy
49,299
+26,343
+115% +$4.72M 0.25% 131
2022
Q4 		$3.82M Buy
+22,956
New +$3.6M 0.11% 320

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $220M AUM 25.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Kennedy Capital Management's MLAB Position: Q1 2026 in Review

Kennedy Capital Management reduced its Mesa Laboratories (MLAB) stake by 1.6% in Q1 2026, selling an estimated $195K and leaving 142,343 shares worth $12.6M. The position accounts for 0.27% of the portfolio, ranked #137.

Kennedy Capital Management first reported a position in MLAB in Q4 2022 and has held it in 14 quarters since. The position peaked at $13.4M in Q1 2025. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.

  • Kennedy Capital Management held 142,343 shares of Mesa Laboratories worth $12.6M as of Q1 2026.
  • Kennedy Capital Management sold 2,263 Mesa Laboratories shares in Q1 2026, an estimated $195K.
  • Mesa Laboratories made up 0.27% of Kennedy Capital Management's portfolio in Q1 2026, its #137 holding.
  • Kennedy Capital Management first reported a position in Mesa Laboratories in Q4 2022 and has held it in 14 quarters since.
  • Kennedy Capital Management's Mesa Laboratories position peaked at $13.4M in Q1 2025.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.